Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share (NQ: EDAP )

1.900 +0.270 (+16.56%)
Streaming Delayed Price Updated: 2:46 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 105,005
Open 1.630
Bid (Size) 1.900 (2)
Ask (Size) 1.930 (1)
Prev. Close 1.630
Today's Range 1.615 - 1.930
52wk Range 1.260 - 7.400
Shares Outstanding 37,103,779
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting
From EDAP TMS S.A.
Via GlobeNewswire

Performance

YTD
-20.83%
-20.83%
1 Month
-12.44%
-12.44%
3 Month
-16.30%
-16.30%
6 Month
-21.16%
-21.16%
1 Year
-73.20%
-73.20%

More News

Read More
This Eastman Chemical Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Via Benzinga
Earnings Preview For Edap TMS
Via Benzinga
A Glimpse of Edap TMS's Earnings Potential
Via Benzinga
This Dow Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results
From EDAP TMS S.A.
Via GlobeNewswire
Earnings Scheduled For March 27, 2025
Via Benzinga
EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Appoints Glen French to Board of Directors
From EDAP TMS S.A.
Via GlobeNewswire
Cortechs.ai and EDAP Announce World’s First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Appoints Joshua H. Levine to Board of Directors
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology
From EDAP TMS S.A.
Via GlobeNewswire
Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Participate in the Piper Sandler 36th Annual Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Scientific Presentation Highlighting Feasibility of Focal One® to Perform Non-thermal Histotripsy Energy Delivery at the 187th Acoustical Society of America Meeting
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Reports Third Quarter 2024 Financial Results
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Participate in the 2024 Jefferies London Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces First Patients Treated in Phase I/II Study Evaluating Focal One Robotic HIFU for the Treatment of Benign Prostatic Hyperplasia (BPH)
From EDAP TMS S.A.
Via GlobeNewswire
EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures
From EDAP TMS S.A.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.